- Home
- HCAT vs ORMP Comparison
HCAT vs ORMP Comparison
Compare HCAT & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCAT | ORMP |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.7M | 134.1M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | HCAT | ORMP |
|---|---|---|
| Price | $1.95 | $3.61 |
| Analyst Decision | Hold | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $4.06 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 168.9K |
| Earning Date | 04-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.40% |
| EPS Growth | ★ 44.98 | N/A |
| EPS | N/A | ★ 1.26 |
| Revenue | ★ $306,584,000.00 | $1,340,000.00 |
| Revenue This Year | $3.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.67 |
| Revenue Growth | ★ 3.60 | N/A |
| 52 Week Low | $1.56 | $1.82 |
| 52 Week High | $5.06 | $3.76 |
Technical Indicators
Market Signals| Indicator | HCAT | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 50.21 | 59.65 |
| Support Level | $1.67 | $3.22 |
| Resistance Level | $2.45 | $3.76 |
| Average True Range (ATR) | 0.15 | 0.20 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 85.39 | 82.54 |
Price Performance
Historical ComparisonAbout HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.